SMTL ID : 2iq9.1

PFA2 FAB fragment, triclinic apo form

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

hetero-1-1-mer

Ligands

2 x ACM: ACETAMIDE(Covalent)

ACM.1: 8 residues within 4Å: Chain A: P.124, F.214, N.215, E.218, C.219 Chain B: V.137, C.138, R.223 3 PLIP interactions: 2 interactions with chain B, 1 interactions with chain A Hydrogen bonds: B:C.138, B:R.223 Hydrophobic interactions: A:F.214 ACM.2: 4 residues within 4Å: Chain A: E.218, C.219 Chain B: C.138, R.223 2 PLIP interactions: 1 interactions with chain A, 1 interactions with chain B Hydrogen bonds: A:C.219 Hydrophobic interactions: B:R.223

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gardberg, A.S. et al., Molecular basis for passive immunotherapy of Alzheimer's disease. Proc.Natl.Acad.Sci.Usa (2007)

Release Date

2007-10-09

Peptides

IgG2a Fab fragment PFA2 Kappa light chain: A
IgG2a Fab fragment PFA2 heavy chain: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
L

B
H

IgG2a Fab fragment PFA2 Kappa light chain

IgG2a Fab fragment PFA2 heavy chain

Related Entries With Identical Sequence